Parkinson’s UK
Sign in / Sign up

Research articles

The case for (and against) Cannabis

The case for (and against) Cannabis

Cannabis may be illegal but there’s growing interest in the potential therapeutic effects for Parkinson’s. We weigh up the evidence so far.
Go to the profile of Claire Bale
Claire Bale
Could growth factors be the key to new treatments for Parkinson’s?

Could growth factors be the key to new treatments for Parkinson’s?

We take a closer look at growth factors and how harnessing their remarkable properties could deliver new treatments for Parkinson’s.
Go to the profile of Claire Bale
Claire Bale
The truth about treatment scams

The truth about treatment scams

We share some tips about what to look out for when deciding if a claim may be a scam.
Go to the profile of Dr Beckie Port
Dr Beckie Port
Four vices that deserve a second look

Four vices that deserve a second look

What do nicotine, high cholesterol and caffeine have in common? The answer, they may all reduce the risk of Parkinson’s.
Go to the profile of Dr Beckie Port
Dr Beckie Port
Time to talk about mental health

Time to talk about mental health

It’s mental health awareness week, so we’re sharing the latest research that aims to tackle mental health problems in Parkinson’s.
Go to the profile of Dr Beckie Port
Dr Beckie Port
Meet the team behind the GDNF trial

Meet the team behind the GDNF trial

Can GDNF treatment slow, stop or reverse the course of Parkinson’s? That’s the question a groundbreaking UK study is attempting to answer.
Go to the profile of Claire Bale
Claire Bale
Can you smell Parkinson’s?

Can you smell Parkinson’s?

Back in 2015, you may have heard the story of a lady called Joy who could smell Parkinson’s. We look at the research that followed this.
Go to the profile of Dr Sophie McLachlan
Dr Sophie McLachlan
How do you solve a problem like apathy?

How do you solve a problem like apathy?

Apathy is much more common in people with Parkinson’s and the impact can be devastating. But what is apathy and what can we do about it?
Go to the profile of Claire Bale
Claire Bale
200 years of Parkinson’s

200 years of Parkinson’s

It’s time to stop Parkinson’s in its tracks.
Go to the profile of Dr Beckie Port
Dr Beckie Port
What’s in the pipeline for Parkinson’s?

What’s in the pipeline for Parkinson’s?

Phenomenal progress in the lab in the last 20 years has produced new potential treatments that are being tested in clinical trials today.
Go to the profile of Claire Bale
Claire Bale
Making sense of Parkinson’s research

Making sense of Parkinson’s research

Are Parkinson’s brain cells reluctant to recycle their worn out batteries?
Go to the profile of Prof David Dexter
Prof David Dexter
From prediction to prevention

From prediction to prevention

Parkinson’s affects around one in 500 people in the UK. But if we could predict Parkinson’s could we prevent it?
Go to the profile of Dr Beckie Port
Dr Beckie Port
The power of placebo

The power of placebo

Is it mind over matter, or is something else behind this powerful phenomenon?
Go to the profile of Dr Beckie Port
Dr Beckie Port
Exercise and Parkinson’s

Exercise and Parkinson’s

When it comes to exercise in Parkinson’s, what does the research say?
Go to the profile of Dr Beckie Port
Dr Beckie Port
Developing the treatments of tomorrow

Developing the treatments of tomorrow

It’s time to develop treatments that do more than just mask the symptoms of Parkinson’s.
Go to the profile of Dr Beckie Port
Dr Beckie Port
A gut feeling about Parkinson’s

A gut feeling about Parkinson’s

Research is leading scientists to believe changes in the gut may play an important role in Parkinson’s.
Go to the profile of Dr Beckie Port
Dr Beckie Port
How the retreat of big pharma leads to lost opportunities for Parkinson’s drug discovery

How the retreat of big pharma leads to lost opportunities for Parkinson’s drug discovery

50 years since the first Parkinson’s medications were discovered, why are we still waiting for better treatments?
Go to the profile of Dr Beckie Port
Dr Beckie Port
A vaccine for Parkinson’s: what are the chances?

A vaccine for Parkinson’s: what are the chances?

Parkinson’s is not an infectious illness. So how could a vaccine help?
Go to the profile of Dr Beckie Port
Dr Beckie Port
Virtual company to create new Parkinson’s treatments

Virtual company to create new Parkinson’s treatments

In a partnership that is the first of its kind, Keapstone Therapeutics aims to develop new treatments.
Go to the profile of Dr Beckie Port
Dr Beckie Port
Parkinson’s. It’s time to get personal.

Parkinson’s. It’s time to get personal.

If you give 100 people with Parkinson’s a drug and half benefit but the other half experience severe side effects, is the drug useless?
Go to the profile of Dr Beckie Port
Dr Beckie Port
Stem cells  —  the story so far…

Stem cells  —  the story so far…

Will stem cell treatments be available in my lifetime? And what are the barriers to making stem cell treatments a reality?
Go to the profile of Dr Beckie Port
Dr Beckie Port
A future of better clinical trials

A future of better clinical trials

The answers to better trials in Parkinson’s may already be out there.
Go to the profile of Dr Beckie Port
Dr Beckie Port
About Parkinson’s UKLatest StoriesArchiveAbout MediumTermsPrivacy